The Effect of Self-management with Family Participation Program on Psychotic Symptoms with Chronic Schizophrenia Patients
Article Sidebar
Main Article Content
Abstract
This quasi-experimental research aimed to examine the effect of self-management with family participation program on psychotic symptoms with chronic schizophrenia patients. Seventy patients with schizophrenia who were treated at the outpatient department with their caregivers were equally randomized-divided into either the experimental and usual care groups. The experimental group received 7 sessions the self-management with family participation program while the control group of 35 people received usual nursing care, which is an activity that nurses and health team personnel provides services for schizophrenic patients and their families in outpatient departments including giving advice on drug use and drug side effects, schizophrenia education and symptomatic counseling of the patient. Research tools consisted of two parts: (1) the self-management with family participation program, questionnaires consisted of general characteristics, Brief Psychiatric Rating Scale (BPRS) and (2) the symptoms management assessment tool (SMST). The data were analyzed using descriptive statistics by comparing mean of psychotic symptom between pre and post in experimental group by using pair samples t-test, and between the experimental and usual care by using independent samples t-test. The results showed that mean score of psychotic symptoms of experimental group after receiving intervention was significantly statistically lower than before (t = 4.87, df = 32, p < .001) and mean score of psychotic symptoms of experimental group after receiving intervention was significantly statistically lower than those receiving usual care (t = -5.98, df = 51.68, p < .001). The findings of this study indicated that self-management with family participation program could decrease psychotic symptoms in schizophrenia patients. Therefore, this program can be implemented within nursing practice in order to decrease psychotic symptoms.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Wang X, Petrini M, Morisky ED. Comparison of the quality of life, perceived stigma and medication adherence of Chinese with schizophrenia: a follow-up study. Arch Psychiatr Nurs 2016;30(1):41-6.
Lean M, Fornells-Ambrojo M, Milton A, Lloyd-Evans B, Harison-Stewart B, Yesufu-Udechuku A, et al. Self-management interventions for people with severe mental illness: systematic review and meta-analysis. British of Psychiatry 2019;214(5):260-86.
American Pharmacists Association. Improving medication adherence in patients with severe mental illness. Pharmacy Today 2013;19(6):69-80.
Liu-Seifert H, Osuntokun OO, Feldman PD. Factor associated with adherence to treatment with olanzapine and other atypical antipsychotic medications in patients with schizophrenia. Compr Psychiatry 2012;53(1):107-15.
Taylor M, Chaudhry I, Cross M, McDonald E, Miller P, Pilowsky L, et al. Towards consensus in the long-term management of relapse prevention in schizophrenia. Human Psychopharmacology 2005;20(3):175-81.
Tan SCH, Yeoh AL, Choo IBK, Huang APH, Ong SH, Ismail H, et al. Burden and coping strategies experienced by caregivers of persons with schizophrenia in the community. J Clin Nurs 2012;21(17-18):2410-8.
Liu-Seifert H, Osuntokun OO, Feldman PD. Factor associated with adherence to treatment with olanzapine and other atypical antipsychotic medications in patients with schizophrenia. Compr Psychiatry 2012;53(1):107-15.
Dassa D, Boyer L, Benoit M, Bourcet S, Raymondet P, Bottai T. Factors associated with medication-adherence in patients suffering from schizophrenia: a cross-sectional study in a universal coverage health-care system. Aust N Z J Psychiatry 2010;44(10):921-8.
Lincoln TM, Wilhelm K, Nestoriuc Y. Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: a meta-analysis. Schizophrenia Res 2007;96(1-3):232-45.
Sari SP, Suttharangsee W, Chanchong W. The effect of self-management with family participation on medication adherence among patients with schizophrenia in Indonesia: a pilot study. Songklanagarind Journal of Nursing 2014;34(Suppl):12-24.
Honkonen T, Saarinen S, Salokangas R. Deinstitutionalization and schizophrenia in Finland II: discharged patients and their psychosocial functioning. Schizophr Bull 1999;25(3):543-51.
Zou H, Li Z, Nolan MT, Arthur D, Wang H, Hu L. Self-management education interventions for persons with schizophrenia: a meta-analysis. Int J Ment Health Nurs 2013;22(3):256-71.
Kanfer FH. Self-management methods. In: Kanfer FH, Goldstein AP, editor. Helping people change: a textbook of methods. 2nd ed. New York: The Pergamon Press; 1980.
Kanfer FH, Gaelick-Buys L. Self-management methods. In: Kanfer FH, Goldstein AP, editor. Helping people change: a textbook of methods. 2nd ed. New York: The Pergamon Press; 1991.
Nuechterlein KH, Dawson ME, Green MF. Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia. Acta Psychiatry Scandinava 1994;384(89):71-9.
McGlashan TH, Hoffman RE. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 2000;57(7):637-48.
Polit DF, Beck CT. Nursing research: principles and methods. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2004.
Kopelowicz A, Zarate R, Gonzalex SV, Mintz J, Liberman RP. Disease management in Latinos with schizophrenia: a family-assisted, skills training approach. Schizophrenia Bulletin 2003;29(2):211-27.
Overall JE, Gorham DR. The brief psychiatric rating scale. Psychological Reports 1962;10(3):799-812.
Kittiratanapiboon P. The project for training, interview guidelines and grading BPRS in the format of T-PANSS. In: supporting documents: lecture on the evaluation of psychiatric patients, Suan Prung Hospital. Chiang Mai: Suan Prung Hospital; 2001.
Murphy MF, Moller MD. Relapse management in neurobiological disorders: The Moller Murphy Symptom Management Assessment Tool. Arch Psychiatr Nurs 1993;7(4):226-35.
Kennedy MG, Schepp KG, O’Connor FW. Symptom self-management and relapse in schizophrenia. Arch Psychiatr Nurs 2000;14(6):266-75.
Changming V, Sitthimongkol Y, Wattanapailin A, Ngamthipwattana T. Relationships among symptom recognition, social support and symptom self-management of schizophrenic patients. The Thai Journal of Nursing Council 2003;18(3):86-99.
Adewuya AO, Owoeye OA, Erinfolami AR, Coker AO, Ogun OC, Okewole AO, et al. Prevalence correlates of poor medication adherence among psychiatric outpatients in South Western Nigeria. Gen Hosp Psychiatry 2009;31(2):167-74.
Anzai N, Yoneda S, Kumagai N, Nakamura Y, Ikebuchi E, Liberman RP. Rehabilitation rounds: training persons with schizophrenia in illness self-management: a randomized controlled trial in Japan. Psychiatry Service 2002;53(5):545-7.
Buccheri R, Trygstad L, Dowling A, Hopkins G, White K, Griffin JJ, et al. Persistent auditory hallucinations in schizophrenia. J Psychosoc Nurs Ment Health Serv 2004;42(1):18-27.
Barkhof E, Meijer, CJ, Sonneville LMJ, Linszen DH, Haan L. Interventions to improve adherence to antipsychotic medication in patients with schizophrenia: a review of the past decade. Eur Psychiatry 2012;27(1):9-18.
Sitthimongkol Y, Klainin-Yobas P, Suthiumnuoykul W, Likitlertlum S. Development of a symptom self-management program for outpatients with schizophrenia and their families in Thailand. Asian Journal of Nursing 2007;10;(2):113-20.
Chan SW, Yip B, Tso S, Cheng B, Tam W. Evaluation of a psychoeducation program for Chinese clients with schizophrenia and their family caregivers. Patient Educ Couns 2009;75(1):67-76.